BioCentury
ARTICLE | Financial News

GSK investing in new Sanderling fund

January 11, 2013 12:59 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it will contribute $50 million to Sanderling Ventures' new $250 million Sanderling VII fund. The pharma did not provide details on the timing of its invest...